Search
for
Sort by
Research 331–360 of 655
- Menopausal Acne – Challenges And Solutions
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Baricitinib for the Treatment of Alopecia Areata
- Update on the Potential of <i>Punica granatum</i> L. Traditional Uses and Pharmacological Uses: A Review
- Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Hormonal Therapies in Cosmetic Dermatology: Mechanisms, Clinical Applications, and Future Perspectives
- Symptomatology of Long COVID Associated with Inherited and Acquired Thrombophilic Conditions: A Systematic Review
- Exploring Hormone Therapy Effects on Reproduction and Health in Transgender Individuals
- Rapid hair regrowth in an alopecia universalis patient with deucravacitinib: A case report
- Abstracts from the 4th Annual Student Medical Summit
- Trailing the Path to Preventive Oncology
- Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review
- Vitiligo—Current Treatment Options and Future Perspectives
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older
- Testosterone Pellets in Women: Revisiting Safety and Clinical Outcomes
- The Burden of Alopecia Areata and Management with Baricitinib in the United Arab Emirates: A Narrative Review
- Review of Promising Off-Label Use of Deucravacitinib
- Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis
- Dermatological Manifestations of COVID-19: A Comprehensive Review
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Carotid Intima Media Thickness Measurement in Alopecia Areata Patients
- The Hormonal Background of Hair Loss in Non-Scarring Alopecias
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases